TSX-V:MDCX - TSX Venture Exchange - CA58471K2020 - Common Stock - Currency: CAD
TSX-V:MDCX (2/21/2025, 7:00:00 PM)
5.69
-0.01 (-0.18%)
The current stock price of MDCX.CA is 5.69 CAD. In the past month the price increased by 44.05%. In the past year, price increased by 164.65%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 261.54M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 188.23M | ||
EDT.CA | SPECTRAL MEDICAL INC | N/A | 185.09M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 121.39M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 89.95M | ||
ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 82.42M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 78.27M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 25.45 | 76.72M | ||
MBX.CA | MICROBIX BIOSYSTEMS INC | 48.5 | 65.22M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 52.45M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 51.96M | ||
HEM.CA | HEMOSTEMIX INC | N/A | 25.50M |
Medicus Pharma Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2023-10-11. Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The firm investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The firm is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.
MEDICUS PHARMA LTD
100 King Street West, Suite 3400
TORONTO ONTARIO CA
Employees: 0
Company Website: https://medicuspharma.com/
Investor Relations: http://medicuspharma.com/investor-relations/
Phone: 17323003046
The current stock price of MDCX.CA is 5.69 CAD. The price decreased by -0.18% in the last trading session.
The exchange symbol of MEDICUS PHARMA LTD is MDCX and it is listed on the TSX Venture Exchange exchange.
MDCX.CA stock is listed on the TSX Venture Exchange exchange.
null analysts have analysed MDCX.CA and the average price target is 7.99 CAD. This implies a price increase of 40.36% is expected in the next year compared to the current price of 5.69. Check the MEDICUS PHARMA LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MEDICUS PHARMA LTD (MDCX.CA) has a market capitalization of 61.74M CAD. This makes MDCX.CA a Micro Cap stock.
MEDICUS PHARMA LTD (MDCX.CA) currently has 0 employees.
MEDICUS PHARMA LTD (MDCX.CA) has a support level at 3.63 and a resistance level at 5.7. Check the full technical report for a detailed analysis of MDCX.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MDCX.CA does not pay a dividend.
ChartMill assigns a technical rating of 10 / 10 to MDCX.CA. When comparing the yearly performance of all stocks, MDCX.CA is one of the better performing stocks in the market, outperforming 96.39% of all stocks.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |